Squamous cell carcinoma
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
Analysis of methylation and mRNA expression status of FADD and FAS genes in patients with oral squamous cell carcinoma.
|
25129245 |
2014 |
Squamous cell carcinoma
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
FAS expression was studied in 60 squamous cell carcinomas of the oral cavity.
|
23894399 |
2013 |
Squamous cell carcinoma
|
0.600 |
Biomarker
|
disease |
BEFREE |
To examine the process of LOH induction, the H292 cell line (human muco-epidermoid carcinoma) was irradiated or treated with anti-CD95 antibody, and individual clones isolated through two rounds of cloning.
|
20607707 |
2010 |
Squamous cell carcinoma
|
0.600 |
AlteredExpression
|
disease |
LHGDN |
Immunohistochemical expression of fatty acid synthase, Ki-67 and p53 in squamous cell carcinomas of the larynx.
|
18949744 |
2009 |
Squamous cell carcinoma
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The interaction between FAS -670AA and FASL -844CC genotypes was associated with a risk of HSIL/SCC (OR 2.13, 95% CI 1.06-4.29) higher than that of the FAS -670AA genotype alone (OR 1.70, 95% CI 1.07-2.70).
|
15996722 |
2005 |
Squamous cell carcinoma
|
0.600 |
AlteredExpression
|
disease |
LHGDN |
Expression of Fas and Fas-ligand and analysis of argyrophilic nucleolar organizer regions in squamous cell carcinoma: relationships with tumor stage and grade, and apoptosis.
|
15907374 |
2005 |
Squamous cell carcinoma
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
The authors studied the expression of CD95 (Fas) in biopsy samples of normal skin (not exposed to sun) and compared it with chronically sun-exposed skin (as evidenced by solar elastosis), AK, squamous cell carcinoma (SCC) and basal cell carcinoma (BCC), and keratoacanthomas (KA).
|
11857317 |
2002 |
Squamous cell carcinoma
|
0.600 |
Biomarker
|
disease |
LHGDN |
Participation of Fas-mediated apoptotic pathway in KB, a human head and neck squamous cell carcinoma cell line, after irradiation.
|
11836578 |
2002 |
Squamous cell carcinoma
|
0.600 |
AlteredExpression
|
disease |
LHGDN |
Immunohistochemical expression of p53, Bcl-2, Bax, and Fas proteins in squamous cell carcinomas from immunosuppressed renal transplant recipients and immunocompetent individuals.
|
12270344 |
2002 |
Squamous cell carcinoma
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
The high expression of CD95 ligand, TRAIL, and FLIP in squamous cell carcinoma may then contribute to the immune escape of the tumor, whereas the lack of expression of CD95 and TRAIL receptors prevents autolysis of the tumor.
|
11442750 |
2001 |
Squamous cell carcinoma
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
In this study, we analyzed the entire coding region and all splice sites of the Fas gene for the detection of the somatic mutations in a series of 50 conventional squamous cell carcinomas and 21 burn scar-related squamous cell carcinomas by polymerase chain reaction, single strand conformation polymorphism, and DNA sequencing.
|
10620127 |
2000 |
Squamous cell carcinoma
|
0.600 |
Biomarker
|
disease |
BEFREE |
Suppression of Fas receptor and negative correlation of Fas ligand with differentiation and apoptosis in oral squamous cell carcinoma.
|
9950255 |
1999 |
Squamous cell carcinoma
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Squamous cell carcinoma
|
0.600 |
CausalMutation
|
disease |
CGI |
|
|
|